Dust mite allergy and the significance of different immunotherapies to treat It.

Thumbnail Image

Date

2022-03

Journal Title

Journal ISSN

Volume Title

Publisher

BRAC University

Abstract

Dust mite allergy is an inflammatory reaction to microscopic insects that reside in household dust. Dust mite allergy symptoms include those associated with hay fever, such as sneezing and a runny nose. Many persons who are allergic to dust mites also exhibit symptoms of asthma, such as wheezing and trouble breathing. Immunotherapy is an important treatment option for dust allergies. Numerous patients are being alleviated by the use of sublingual or subcutaneous immunotherapy, which provides more alleviation for a longer length of time and is devoid of adverse effects, in contrast to synthetic medications. Sublingual immunotherapy (SLIT) allergy pills are a new type of allergy immunotherapy that was recently licensed in the United States. Instead of injections, allergy tablets entail sublingual administration of allergens with in form of a liquid or tablet on a regular basis. Subcutaneous immunotherapy (SCIT) is a very well kind of this treatment. Additional allergens, including such venoms or food allergies, are examined independently in SCIT. Oral and sublingual immunotherapy, rush immunotherapy, mechanisms of action, and allergen extract production are all covered separately.

Description

This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2022.
Cataloged from PDF version of thesis.
Includes bibliographical references (pages 54-63).

Keywords

Dust, Allergy, Immunotherapy, Sublingual, Subcutaneous

Citation

Endorsement

Review

Supplemented By

Referenced By